Success Story: From Veterinary Genomics to Approval! NIW Approved for a Veterinary Medicine Expert
Client’s Testimonial:
"Thanks for the support throughout the EB2-NIW process. I really appreciate the service.”
On March 25th, 2026, we received an EB-2 NIW (National Interest Waiver) approval for an International Postdoctoral Research Associate in the Field of Veterinary Medicine (Approval Notice).
General Field: Veterinary Medicine
Position at the Time of Case Filing: International Postdoctoral Research Associate
Country of Origin: India
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: March 25th, 2026
Processing Time: 11 months, 23 days (Premium Processing Requested)
Case Summary:
This NIW case centered on a client with a Ph.D. in veterinary virology, veterinary bacteriology, and animal biotechnology whose work combines veterinary medicine, genomics, and diagnostic innovation. Rather than framing the case around credentials alone, the petition showed why the client’s research trajectory matters in practical terms. The case was approved under the I-140 National Interest Waiver category after the record showed both the national importance of this work and the client’s strong positioning to advance it.
What the Client Proposed to Do
As presented in the filing, the client’s proposed endeavor was to continue research on rapid diagnostic technology for non-invasive tumor detection in animals. The petition explained why this matters beyond technical novelty. In veterinary oncology, later diagnosis often means higher treatment costs, more invasive intervention, and poorer outcomes. By contrast, earlier non-invasive detection can improve survival prospects while making advanced diagnostics more practical and more accessible.
How We Framed National Importance
The significance argument was not that animal cancer is unfortunate and therefore any related work must be nationally important. Instead, the petition tied the proposed endeavor to broader U.S. interests in veterinary biotechnology, precision medicine, and cost-effective animal healthcare. The filing emphasized the high incidence of cancer in companion animals, the financial burden associated with pet healthcare, and the need for better diagnostic methods than invasive procedures that can be expensive and difficult to access. That framing matters in NIW cases because adjudicators are not simply evaluating whether the research is worthwhile, but whether it has implications broad enough to rise to national importance.
The case was strengthened further by evidence that the client’s research attracted major support from the Georgia Agricultural Commodity Commission for Beef, the American Kennel Club Canine Health Foundation, and the U.S. Food and Drug Administration Vet-LIRN. In an NIW context, that kind of funding helps show that recognized institutions saw practical value in the client’s work and considered it relevant to animal health, disease surveillance, and broader public-facing needs.
Why the Client Was Well Positioned
The petition then turned to the client’s record of success. The client had authored 37 peer-reviewed journal articles, including 12 first-authored papers, along with 2 book chapters. His work had been cited 351 times, and he had completed at least 13 peer reviews. Those numbers were useful, but the case did not ask USCIS to treat them as self-proving. Instead, the petition explained what they signaled.
The petition included 4 recommendation letters from experts in the field. One recommender noted:
“Ensuring that [Client’s] work proceeds is thus not only important to the field, but to the United States as well.”
Case Outcome
This I-140 NIW approval reflects more than a strong academic record. It reflects a case built around a forward-looking endeavor, a clear explanation of national importance, meaningful third-party funding support, and a record showing that the client’s research has already earned publication, citation, and peer trust in the field. We were pleased to help present a focused case showing why the client’s continued work in veterinary diagnostic innovation would benefit the United States.